Can Shingles Cause Muscle Weakness in Legs?

Shingles can cause muscle weakness in the legs, though it happens far less often than the burning pain and blistered rash that most people associate with the disease. The condition is called segmental zoster paresis, and it is estimated to affect roughly 3 to 5 percent of people who develop shingles.¹ The weakness can range from a subtle heaviness in one leg to a full inability to lift the foot, and the path from rash to recovery is more complicated than most people realize.

How Shingles Attacks the Nerves That Move Your Legs

The varicella-zoster virus, the same virus that causes chickenpox, hides in nerve cell clusters along the spine after the initial childhood infection. When it reactivates decades later as shingles, it usually travels along sensory nerve fibers and produces a painful rash in a strip-like pattern on the skin. But the virus does not always stay confined to sensory nerves. In some cases it spreads to nearby motor nerve roots or to the spinal cord itself, damaging the fibers responsible for sending movement signals to muscles. When that damage hits the nerve roots that supply the legs, the result is weakness or even paralysis in the affected limb.

In the lower extremities, the nerve roots most commonly involved are those in the lumbar spine, roughly from L1 through L4.² The motor damage can take several forms. In a study that examined dozens of cases, roughly four in ten involved the nerve plexus (the branching network where spinal nerves converge before heading into the limb), about a third involved single nerve roots, and a smaller share involved individual peripheral nerves.³ In practical terms, the virus can cause trouble at several different points along the nerve pathway, which is part of what makes the resulting weakness so variable from person to person.

What Leg Weakness From Shingles Looks Like

The weakness usually appears on the same side as the rash and in the muscle group that corresponds to the affected nerve root. If the virus hits the L5 root, for instance, you might lose the ability to pull your foot upward, a condition called foot drop. If it hits nerves higher in the lumbar spine, the thigh or hip muscles may weaken instead, making it hard to climb stairs or rise from a chair. In the same study noted above, the lower limb was the affected area in about 55 percent of cases, and the average severity was moderate, meaning noticeable loss of strength but not complete paralysis.³

Pain almost always accompanies the weakness and often precedes it. Over nine in ten patients in that cohort had postherpetic neuralgia at the one-month mark, and about two-thirds still had it three months later.³ So the typical experience is burning or shooting pain in a band along one side of the lower back, buttock, or leg, followed some days or weeks later by difficulty moving part of that leg. The weakness itself tends to set in about two to three weeks after the rash first appears.¹ That delay can cause confusion, because by the time the leg starts giving out, the rash may already be fading and no longer look like the obvious culprit.

Foot Drop as a Common Presentation

Among leg-related cases, foot drop gets reported particularly often in clinical literature. The pattern is recognizable: a person develops a shingles rash on the lower back, buttock, or thigh, and within a few weeks they cannot lift the front of one foot, causing them to trip or drag the toe while walking. Case reports describe this in patients across age groups, though it tends to appear most often in older adults. In one published case, an 81-year-old woman developed an inability to lift her right foot about four weeks after a shingles outbreak in the L4-L5 area, despite having been treated with antiviral medication.⁴

Two other patients, both men in their seventies, were initially referred to an orthopedic clinic for foot and leg weakness because their doctors suspected a spinal disc problem. In both cases the actual cause turned out to be shingles affecting the motor nerves.⁵ These misreferrals illustrate a pattern worth understanding: because the rash may be in an area that is not easily seen (the buttock, the lower back), and because leg weakness plus back pain sounds exactly like a herniated disc, shingles-related weakness is frequently mistaken for a spinal problem.

Why It Gets Mistaken for a Disc Problem

The overlap with spinal conditions is the single biggest diagnostic pitfall. Leg pain, numbness, and weakness in a pattern that follows a nerve root is the textbook description of a pinched nerve from a bulging disc, and it is also a textbook description of zoster-associated paresis. In a physiotherapy setting, where patients commonly present with exactly these symptoms, the possibility of shingles as the underlying cause is not always considered.⁶ Even when spine imaging is performed, it can muddy the picture further: many older adults have degenerative disc changes that show up on an MRI regardless of whether those changes are causing the current symptoms. A clinician might see narrowing of the spinal canal on imaging and attribute the weakness to that, missing the real viral cause entirely.

Getting the diagnosis right matters because the treatment paths are different. A disc-related problem might be managed with injections or surgery, while zoster paresis calls for antiviral medications and sometimes corticosteroids. Misdiagnosis can lead to unnecessary procedures and delayed antiviral treatment, which may reduce the chances of a full recovery.

When There Is No Rash at All

One of the more unsettling aspects of zoster-related weakness is that it can occasionally occur without a visible rash, a phenomenon sometimes called zoster sine herpete. In one published case, a 48-year-old woman developed weakness in her right leg that was eventually traced to herpes zoster reactivation, and she experienced repeated relapses of leg weakness over time, sometimes without any prominent rash.⁷ Cases like this are rare, but they make the diagnostic challenge even harder. Without a rash to point toward the virus, clinicians may not think to test for it, and the weakness may be attributed to a stroke, a neurological disease, or an orthopedic issue. Blood tests or spinal fluid analysis for varicella-zoster antibodies can confirm the diagnosis, but those tests are only ordered when someone suspects the virus in the first place.

When the Spinal Cord Itself Is Involved

The motor weakness described above comes from the virus damaging individual nerve roots or the nerve plexus. But in rarer and more serious cases, the virus can invade the spinal cord directly, a condition called herpes zoster myelitis. When that happens, the damage is more widespread and the resulting neurological problems more severe. In a case series published in the journal Brain, the neurological symptoms were typically on the same side as the rash, with motor problems predominating over sensory loss.⁸

A more recent case report described a patient whose left lower limb weakness and sensory changes were traced to viral damage to motor neurons and nerve tracts within the spinal cord itself.⁹ Another case involved a 43-year-old man who developed weakness in both legs (worse on the left), along with difficulty urinating, five days after a shingles outbreak. Imaging showed inflammation spanning several segments of his spinal cord, and spinal fluid testing confirmed the presence of the virus.¹⁰ That patient also turned out to have undiagnosed HIV, which underscores that people with weakened immune systems face a higher risk of these severe complications.

Beyond direct nerve and spinal cord invasion, the varicella-zoster virus can also damage blood vessels, a process called VZV vasculopathy. This can lead to reduced blood flow and even small strokes in the brain or spinal cord.¹¹ When the spinal cord’s blood supply is compromised, the resulting damage can produce sudden weakness or numbness in the legs. This mechanism is distinct from the direct viral attack on nerves and tends to be more sudden in onset.

The Guillain-Barré Connection

In rare cases, shingles can also trigger Guillain-Barré syndrome, a condition where the immune system attacks the body’s own peripheral nerves. This produces rapidly progressive weakness that typically starts in the legs and moves upward, and it is a medical emergency. Guillain-Barré can be triggered by many different infections, and varicella-zoster virus is an uncommon but recognized trigger.¹² A systematic review pooling published case reports found that when Guillain-Barré followed a varicella-zoster infection, most patients had weakness affecting all four limbs and many had cranial nerve problems as well.¹³

The distinction between Guillain-Barré and segmental zoster paresis matters because the treatments are different. Segmental paresis is managed with antivirals and sometimes steroids, while Guillain-Barré typically requires immunotherapy in a hospital setting. The key clinical clue is the pattern of weakness: zoster paresis stays localized to the area near the rash, while Guillain-Barré spreads symmetrically and rapidly beyond any single nerve root territory.

How the Diagnosis Is Confirmed

When a visible rash is present alongside the weakness, the diagnosis is fairly straightforward for a clinician who considers it. The rash’s location tells you which nerve root is likely involved, and the timing of weakness onset a few weeks later fits the known pattern. When the picture is less clear, whether because the rash has faded, appeared in a hidden location, or never appeared at all, additional tests come into play.

Electromyography, a test that records the electrical activity of muscles, is the primary tool for confirming nerve damage. In patients with zoster paresis, these tests consistently show abnormal spontaneous electrical activity in the affected muscles, confirming that the motor nerves have been injured.¹⁴ Spinal MRI may be ordered to rule out disc herniation or other structural causes. Blood tests and cerebrospinal fluid analysis can detect antibodies or viral DNA from varicella-zoster, which is particularly useful when there is no rash to guide the diagnosis.

Treatment and How Long Recovery Takes

The standard first step is antiviral medication, usually acyclovir or valacyclovir, ideally started as soon as possible after the rash appears. Whether antivirals change the course of the motor weakness specifically, as opposed to the rash and pain, is less clear from the evidence. By the time weakness develops weeks after the rash, the window for antiviral benefit may have partially closed. Corticosteroids are sometimes added to reduce inflammation around the affected nerves. In one case described in the Mayo Clinic Proceedings, a patient’s pain improved dramatically within a day of starting prednisone, and strength gradually returned over the following months, though mild residual weakness persisted at five months.¹⁵

Recovery from zoster-related leg weakness is slow. In the clinical study that tracked outcomes across many patients, the average minimum duration of weakness was about six and a half months.³ Some patients recover full strength, while others are left with permanent residual weakness. The severity of the initial nerve damage appears to be the biggest factor in how much strength returns. People who had only moderate weakness tend to fare better than those who lost strength completely. Age and immune status also play roles, since older and immunocompromised patients tend to have more extensive nerve damage in the first place.

For patients dealing with foot drop specifically, an ankle-foot orthosis (a lightweight brace that holds the foot up) can make a significant practical difference during recovery, preventing falls and allowing more normal walking while the nerve heals. Two of the foot drop patients described in the orthopedic literature were managed with foot drop splints alongside their antiviral treatment.⁵

The Role of Rehabilitation

Physical therapy is an underappreciated part of recovering from shingles-related weakness. A review of cases involving polyradiculopathy from herpes zoster found that physical and occupational therapy played a key role in restoring motor function, yet published research on rehabilitation for this specific problem remains sparse.¹⁶ Because nerve regeneration after viral damage can take many months, structured exercise helps maintain muscle mass and joint flexibility in the affected leg while the nerves slowly repair themselves. Without rehabilitation, the muscles supplied by the damaged nerve can atrophy, making recovery harder even after nerve function starts to return.

The exercises involved are not exotic. Strengthening the weak muscles with gradual resistance, maintaining range of motion, and practicing balance and gait are the core of the program. For someone with foot drop, targeted exercises for the shin muscles that lift the foot are combined with functional training to reduce fall risk. The key message from the rehabilitation literature is that passive waiting for the nerve to heal is not the best strategy; actively working the affected muscles and limb improves outcomes.

Who Is Most at Risk

Shingles itself is more common and more severe in people over 50 and in anyone with a compromised immune system, whether from HIV, cancer treatment, organ transplant medications, or chronic conditions like diabetes. The motor complication follows the same risk profile. The average age in the largest published case series was 71 years, and men were affected about twice as often as women.³ Whether male predominance reflects a true biological difference or just a reporting artifact is not settled.

Vaccination is the most effective way to prevent shingles and its complications, including motor weakness. The recombinant zoster vaccine available today is recommended for adults 50 and older and for immunocompromised adults 19 and older. It does not eliminate the risk of shingles entirely, but it significantly reduces the likelihood and severity of an outbreak. Since motor weakness is a downstream complication of the infection, preventing or attenuating the infection itself is the best protection against leg weakness. For someone who has already developed shingles, early antiviral treatment remains the most important step, even though its specific effect on preventing later motor involvement is not firmly established by controlled trials.